Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Stemtech Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
STEK
Over the counter
2836
https://www.stemtech.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Stemtech Corp
Stemtech Corporation on Track for CEO and Chairman's Goal for Growth and Global Expansion
- Apr 19th, 2024 12:30 pm
Stemtech Corporation Announces Darryl V. Green to Direct Company Rebranding Project
- Apr 2nd, 2024 8:15 pm
Stemtech Surges Ahead: Meeting Global Demand with Innovative Stem Cell Nutraceuticals
- Mar 7th, 2024 2:45 pm
Exclusive Events in Doral Florida and Guadalajara Mexico to Showcase Stemtech Revolutionary Stem Cell Nutritional Products
- Feb 21st, 2024 2:00 pm
Stemtech Corporation Expands Global Reach with New License Agreement in Africa
- Jan 31st, 2024 1:30 pm
"Stemtech's Annual Incentive Cruise Sets Sail With Top Earners on Board; Colombia Pre-Registration Now Open and Product Expansion Unveiled for Ecuador"
- Dec 12th, 2023 2:55 pm
Stemtech Continues to Demonstrate Remarkable Growth and Innovation in 2023
- Dec 4th, 2023 1:30 pm
Stemtech Corporation Chairman & CEO Charles S. Arnold and President & COO John W. Meyer to Join (Wolf) "X" Twitter Spaces Session on October 17th at 6:45 PM EST
- Oct 16th, 2023 2:00 pm
Pioneering Stem Cell Nutrition Company Elevating Wellness and Prosperity Together
- Sep 5th, 2023 12:30 pm
Stemtech Announces China Market Expansion
- Aug 14th, 2023 12:30 pm
Stemtech Showcases Remarkable Strides in Business Development and Revenue Growth
- Aug 7th, 2023 12:45 pm
STEMTECH (OTCQB: STEK) Shatters Records with Surge in New Recruits, Paving the Way for a Thrilling Era of Opportunity in the Booming Global Stem Cell Market
- Jul 17th, 2023 12:30 pm
Stemtech Corporation Announces Additional Debt Conversions: Provides Growth Update
- Jul 6th, 2023 3:30 pm
Stemtech Corporation Empowers Growth With Debt-to-Equity Conversion, Strengthening Investor Confidence
- Jun 13th, 2023 12:30 pm
Stemtech Corporation Announces Debt Restructuring
- May 23rd, 2023 1:35 pm
Stemtech Corporation and Union Blue Usa(TM) Announce Revolutionary Alliance To Improve Health and Wellness of Labor Union Members
- May 17th, 2023 12:30 pm
Stemtech Corporation Announces Jeff M. Weisberg as Director of New Business Development
- May 8th, 2023 1:15 pm
Stemtech Announces Business Academies For Mexico And U.S. Independent Business Partners
- Apr 28th, 2023 12:30 pm
Scroll